1. Home
  2. QNCX
  3. QNCX News

Latest Quince Therapeutics Inc. (QNCX) News on July 27, 2024

Quince Therapeutics doses first subject in Ataxia-Telangiectasia trial

Clinical Trials Arena

a month ago

Quince Therapeutics doses first subject in Ataxia-Telangiectasia trial

Share on Social Networks: